Charles River’s Memphis cell therapy facility gains entry into European Union market

Charles River’s Memphis cell therapy facility gains entry into European Union market
·2 min read

“Receiving the GMP certification allows [our] Memphis [facility] to manufacture commercial-grade cell therapy drug products for distribution in Europe.”